We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Bristol Myers Squibb Co | NYSE:BMY | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.515 | -1.15% | 44.125 | 44.76 | 43.97 | 44.43 | 10,654,255 | 20:42:14 |
From Apr 2022 to Apr 2024
10:29 ET -- Bristol Myers Squibb is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The pharmaceutical company reported fourth-quarter sales of $11.41 billion, lower than $11.99 billion in the prior-year period, but higher than expectations of $11.19 billion from analysts polled by FactSet. Profit came out at $2.02 billion, or 95 cents a share, below last year's $2.37 billion in profit, or $1.07 a share, and analyst expectations of $2.26 billion in profit or $0.82 a share. Earnings on an adjusted basis were $1.82 a share, above analyst expectations of $1.73. Dow Jones & Co. owns Factiva. (ada.hui@wsj.com)
(END) Dow Jones Newswires
February 02, 2023 10:44 ET (15:44 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Bristol Myers Squibb Chart |
1 Month Bristol Myers Squibb Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
